Sequencing Study Detects New Prostate Cancer Gene Fusions | GenomeWeb

NEW YORK (GenomeWeb News) — A transcriptome-sequencing study using a combination of long- and short-read sequencing technologies made by Roche 454 and Illumina has identified new gene fusions involved in prostate cancer.

In the study, which appears in yesterday's online edition of Nature, a team of University of Michigan researchers searched for new gene fusions in prostate cancer by sequencing the transcriptomes of patient cell lines and tumor samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.